222 related articles for article (PubMed ID: 26180004)
1. MicroRNAs Determining Inflammation as Novel Biomarkers and Potential Therapeutic Targets.
Kotsinas A; Sigala F; Garbis SD; Galyfos G; Filis K; Vougas K; Papalampros A; Johnson EE; Chronopoulos E; Georgakilas AG; Gorgoulis VG
Curr Med Chem; 2015; 22(22):2666-79. PubMed ID: 26180004
[TBL] [Abstract][Full Text] [Related]
2. Small Molecules with Big Impacts on Cardiovascular Diseases.
Mirzadeh Azad F; Arabian M; Maleki M; Malakootian M
Biochem Genet; 2020 Jun; 58(3):359-383. PubMed ID: 31997044
[TBL] [Abstract][Full Text] [Related]
3. Challenges in Using Circulating Micro-RNAs as Biomarkers for Cardiovascular Diseases.
Felekkis K; Papaneophytou C
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952319
[TBL] [Abstract][Full Text] [Related]
4. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.
Zhou SS; Jin JP; Wang JQ; Zhang ZG; Freedman JH; Zheng Y; Cai L
Acta Pharmacol Sin; 2018 Jul; 39(7):1073-1084. PubMed ID: 29877320
[TBL] [Abstract][Full Text] [Related]
5. Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review.
Navickas R; Gal D; Laucevičius A; Taparauskaitė A; Zdanytė M; Holvoet P
Cardiovasc Res; 2016 Sep; 111(4):322-37. PubMed ID: 27357636
[TBL] [Abstract][Full Text] [Related]
6. microRNAs in cardiovascular disease - clinical application.
Schulte C; Karakas M; Zeller T
Clin Chem Lab Med; 2017 May; 55(5):687-704. PubMed ID: 27914211
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-30 and 145 as Targets for the Treatment of Cardiovascular Diseases: Therapeutic Feasibility and Challenges.
Tolouei SEL; Curi TZ; Klider LM; Junior AG
Curr Pharm Des; 2021; 27(37):3858-3870. PubMed ID: 33308116
[TBL] [Abstract][Full Text] [Related]
8. [Epigenetic factors in atherogenesis: microRNA].
Smirnova AV; Sukhorukov VN; Karagodin VP; Orekhov AN
Biomed Khim; 2016; 62(2):134-40. PubMed ID: 27143369
[TBL] [Abstract][Full Text] [Related]
9. Role of miRNAs on the Pathophysiology of Cardiovascular Diseases.
Silva DCPD; Carneiro FD; Almeida KC; Fernandes-Santos C
Arq Bras Cardiol; 2018 Nov; 111(5):738-746. PubMed ID: 30484515
[TBL] [Abstract][Full Text] [Related]
10. miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204.
Yang Y; Yu T; Jiang S; Zhang Y; Li M; Tang N; Ponnusamy M; Wang JX; Li PF
Expert Opin Ther Pat; 2017 Sep; 27(9):1021-1029. PubMed ID: 28627982
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs as Potential Biomarkers in Atherosclerosis.
Churov A; Summerhill V; Grechko A; Orekhova V; Orekhov A
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31703274
[TBL] [Abstract][Full Text] [Related]
12. Emerging role of microRNAs in cardiovascular diseases.
De Rosa S; Curcio A; Indolfi C
Circ J; 2014; 78(3):567-75. PubMed ID: 24521764
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs Mediate Beneficial Effects of Exercise in Heart.
Bei Y; Tao L; Cretoiu D; Cretoiu SM; Xiao J
Adv Exp Med Biol; 2017; 1000():261-280. PubMed ID: 29098626
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs: roles in cardiovascular development and disease.
Kalayinia S; Arjmand F; Maleki M; Malakootian M; Singh CP
Cardiovasc Pathol; 2021; 50():107296. PubMed ID: 33022373
[TBL] [Abstract][Full Text] [Related]
15. Crafting a Blueprint for MicroRNA in Cardiovascular Diseases (CVDs).
Khan SU; Saeed S; Sheikh AN; Arbi FM; Shahzad A; Faryal U; Lu K
Curr Probl Cardiol; 2023 Dec; 48(12):102010. PubMed ID: 37544621
[TBL] [Abstract][Full Text] [Related]
16. The good, the bad and the ugly: the impact of extracellular vesicles on the cardiovascular system.
Martins-Marques T; Girão H
J Physiol; 2023 Nov; 601(22):4837-4852. PubMed ID: 35348208
[TBL] [Abstract][Full Text] [Related]
17. Regulatory RNAs and cardiovascular disease - with a special focus on circulating microRNAs.
Dlouhá D; Hubáček JA
Physiol Res; 2017 Apr; 66(Suppl 1):S21-S38. PubMed ID: 28379027
[TBL] [Abstract][Full Text] [Related]
18. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease.
Ferrario CM; Strawn WB
Am J Cardiol; 2006 Jul; 98(1):121-8. PubMed ID: 16784934
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases.
Hang P; Guo J; Sun C; Du Z
Curr Drug Targets; 2017; 18(4):463-472. PubMed ID: 26926467
[TBL] [Abstract][Full Text] [Related]
20. Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases.
Kondkar AA; Abu-Amero KK
Biomed Res Int; 2015; 2015():821823. PubMed ID: 25710029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
